Johnson & Johnson will supply the USA with 100 million doses of Ad26 coronavirus vaccine for $1 billion. Currently, the USA and Belgium are going through phase 1/2a of Ad26 candidate vaccine clinical trials on healthy volunteers. Delivery of the drug will be carried out only after receiving FDA approval or permission for emergency use of the vaccine.